← Leaderboards
Natalia Gomez-Ospina
Stanford University
$1,035,180
Attributed
$1,035,180
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.2K · FY2017–22$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,035,180 · 1
By mechanism
K08$1,035,180 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Wei Xu$7,233,203
- Pascal Simon Kaeser$17,347,981
- Terence D Sanger$9,327,215
- Phyllis A. Dennery$8,393,007
- Gary K Steinberg$22,141,624
Others in their field
Other Emerging Leaders on “Hematopoietic Stem Cells”
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Daniel Lucas · Cincinnati Childrens Hosp Med Ctr$9,614,171
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,938,136
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$7,934,488
- Robert A.j. Signer · University Of California, San Diego$7,073,723
Research focus
Hematopoietic Stem CellsModel DesignEngraftmentHematopoieticImmunocompromised HostMethodologyDesignEffective TherapyEnzymesGenome EditingHematopoietic Stem Cell TransplantationHematopoietic SystemLysosomal Storage DiseasesBody SystemAllogenicCrispr/Cas TechnologyDisease ProgressionCcr5 GeneBiochemicalEnzyme Replacement TherapyCellsGenetic EngineeringAffectMouse Model
Grant awards (6)
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$54,000
K08 · FY2022 · NS · contact PI
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$196,236
K08 · FY2021 · NS · contact PI
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$196,236
K08 · FY2020 · NS · contact PI
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$196,236
K08 · FY2019 · NS · contact PI
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$196,236
K08 · FY2018 · NS · contact PI
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing$196,236
K08 · FY2017 · NS · contact PI